Trade Summary

4 days ago, Schwab Andrew J., serving as Dir at Skye Bioscience, Inc. (SKYE), sold 375,840 shares at $0.37 per share, for a total transaction value of $140,313.00. Following this transaction, Schwab Andrew J. now holds 7,850,155 shares of SKYE.

This sale represents a 4.57% decrease in Schwab Andrew J.'s stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, August 18, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, August 20, 2026 at 5:59 PM ET, 2 days after the trade was made.

Skye Bioscience, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.